Onasemnogene Abeparvovec — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

6 Countries

Phase III

Phase III: 2

Indications tested

2 total

Long-term follow-up of patients with spinal muscular atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trials Ended

2024-511707-42-00 Phase III 6 countries Novartis Pharma AG
N/A Ended

2024-513086-39-00 Phase III 3 countries Novartis Pharma AG

Showing 1–2 of 2 trials